Filing Details
- Accession Number:
- 0001567619-18-005093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-05 17:03:41
- Reporting Period:
- 2018-11-01
- Accepted Time:
- 2018-11-05 17:03:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-01 | 2,011 | $25.62 | 31,264 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-01 | 2,011 | $63.50 | 29,253 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-11-02 | 6,168 | $25.62 | 35,421 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-02 | 6,168 | $64.50 | 29,253 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-11-01 | 2,011 | $0.00 | 2,011 | $25.62 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-11-02 | 6,168 | $0.00 | 6,168 | $25.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,168 | 2021-03-10 | No | 4 | M | Direct | |
| 0 | 2021-03-10 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- Consists of an option granted under the company's stock incentive plan as amended and restated.
- The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Billionaire Hedge Funds
